{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T13:16:20Z","timestamp":1783516580226,"version":"3.55.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"DOI":"10.1007\/s00192-026-06793-3","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T12:30:30Z","timestamp":1783513830000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intravesical HA\/EGF Salvage Therapy for Hyaluronic Acid-Refractory Interstitial Cystitis\/Bladder Pain Syndrome: A Small Retrospective Pilot Case Series"],"prefix":"10.1007","author":[{"given":"Wen-Chen","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3764-3854","authenticated-orcid":false,"given":"Jenn-Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"6793_CR1","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1002\/nau.24959","volume":"41","author":"NN Mishra","year":"2022","unstructured":"Mishra NN. Interstitial cystitis\/bladder pain syndrome (IC\/BPS): single-center 20 year experience and treatment results in India. Neurourol Urodyn. 2022;41:1390\u20138.","journal-title":"Neurourol Urodyn"},{"key":"6793_CR2","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/iju.14229","volume":"27","author":"Y Akiyama","year":"2020","unstructured":"Akiyama Y, Luo Y, Hanno PM, Maeda D, Homma Y. Interstitial cystitis\/bladder pain syndrome: the evolving landscape, animal models and future perspectives. Int J Urol. 2020;27:491\u2013503.","journal-title":"Int J Urol"},{"key":"6793_CR3","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.3390\/biomedicines10102380","volume":"10","author":"JF Jhang","year":"2022","unstructured":"Jhang JF, Jiang YH, Kuo HC. Current understanding of the pathophysiology and novel treatments of interstitial cystitis\/bladder pain syndrome. Biomedicines. 2022;10:2380.","journal-title":"Biomedicines"},{"key":"6793_CR4","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1159\/000447863","volume":"39","author":"JS Pyo","year":"2016","unstructured":"Pyo JS, Cho WJ. Systematic review and meta-analysis of intravesical hyaluronic acid and hyaluronic acid\/chondroitin sulfate instillation for interstitial cystitis\/painful bladder syndrome. Cell Physiol Biochem. 2016;39:1618\u201325.","journal-title":"Cell Physiol Biochem"},{"key":"6793_CR5","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s00192-015-2890-7","volume":"27","author":"JM Barua","year":"2016","unstructured":"Barua JM, Arance I, Angulo JC, Riedl CR. A systematic review and meta-analysis on the efficacy of intravesical therapy for bladder pain syndrome\/interstitial cystitis. Int Urogynecol J. 2016;27:1137\u201347.","journal-title":"Int Urogynecol J"},{"key":"6793_CR6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1442-2042.2012.03135.x","volume":"20","author":"MC Lai","year":"2013","unstructured":"Lai MC, Kuo YC, Kuo HC. Intravesical hyaluronic acid for interstitial cystitis\/painful bladder syndrome: a comparative randomized assessment of different regimens. Int J Urol. 2013;20:203\u20137.","journal-title":"Int J Urol"},{"key":"6793_CR7","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1097\/JCMA.0000000000000498","volume":"84","author":"CP Tsai","year":"2021","unstructured":"Tsai CP, Yang JM, Liang SJ, Lin YH, Huang WC, Lin TY, et al. Factors associated with treatment outcomes after intravesical hyaluronic acid therapy in women with refractory interstitial cystitis: a prospective, multicenter study. J Chin Med Assoc. 2021;84:418\u201322.","journal-title":"J Chin Med Assoc"},{"key":"6793_CR8","unstructured":"Riedl CR, Morales A (2018) A prospective randomized placebo-controlled multicenter study on the efficacy of intravesical hyaluronan in bladder pain syndrome\/interstitial cystitis and considerations for designing future trials. Urology: Res Therapeut J 2:120."},{"key":"6793_CR9","doi-asserted-by":"publisher","first-page":"S95","DOI":"10.5213\/inj.1632712.356","volume":"20","author":"JF Jhang","year":"2016","unstructured":"Jhang JF, Kuo HC. Pathomechanism of interstitial cystitis\/bladder pain syndrome and mapping the heterogeneity of disease. Int Neurourol J. 2016;20:S95\u2013104.","journal-title":"Int Neurourol J"},{"key":"6793_CR10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/MOU.0000000000001147","volume":"34","author":"C van Ginkel","year":"2024","unstructured":"van Ginkel C, Hurst RE, Janssen D. The urothelial barrier in interstitial cystitis\/bladder pain syndrome: its form and function, an overview of preclinical models. Curr Opin Urol. 2024;34:77\u201383.","journal-title":"Curr Opin Urol"},{"key":"6793_CR11","doi-asserted-by":"publisher","first-page":"106","DOI":"10.5213\/inj.2448028.014","volume":"28","author":"CC Lin","year":"2024","unstructured":"Lin CC, Yang JM, Hsu TH, Lee HL. Intravesical instillation of hyaluronic acid with epidermal growth factor for restoring urothelial denudation and alleviating oxidative stress in lipopolysaccharide-induced interstitial cystitis of rats. Int Neurourol J. 2024;28:106\u201314.","journal-title":"Int Neurourol J"},{"key":"6793_CR12","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1016\/S0022-5347(01)64786-4","volume":"157","author":"LS Baskin","year":"1997","unstructured":"Baskin LS, Sutherland RS, Thomson AA, Nguyen HT, Morgan DM, Hayward SW, et al. Growth factors in bladder wound healing. J Urol. 1997;157:2388\u201395.","journal-title":"J Urol"},{"key":"6793_CR13","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s00240-002-0260-7","volume":"30","author":"EMJ Bindels","year":"2002","unstructured":"Bindels EMJ, van der Kwast TH, Izadifar V, Chopin DK, de Boer WI. Functions of epidermal growth factor-like growth factors during human urothelial reepithelialization in vitro and the role of ErbB2. Urol Res. 2002;30:240\u20137.","journal-title":"Urol Res"},{"key":"6793_CR14","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1097\/01.LAB.0000086380.23263.52","volume":"83","author":"A Daher","year":"2003","unstructured":"Daher A, de Boer WI, El-Marjou A, van der Kwast T, Abbou CC, Thiery JP, et al. Epidermal growth factor receptor regulates normal urothelial regeneration. Lab Invest. 2003;83:1333\u201341.","journal-title":"Lab Invest"},{"key":"6793_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/diagnostics12010075","volume":"12","author":"HY Lin","year":"2022","unstructured":"Lin HY, Lu JH, Chuang SM, Chueh KS, Juan TJ, Liu YC, et al. Urinary biomarkers in interstitial cystitis\/bladder pain syndrome and its impact on therapeutic outcome. Diagnostics (Basel). 2022;12:75.","journal-title":"Diagnostics (Basel)"},{"issue":"Suppl 1","key":"6793_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/iju.12311","volume":"21","author":"HC Kuo","year":"2014","unstructured":"Kuo HC. Potential urine and serum biomarkers for patients with bladder pain syndrome\/interstitial cystitis. Int J Urol. 2014;21(Suppl 1):34\u201341.","journal-title":"Int J Urol"},{"key":"6793_CR17","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3390\/biom16010138","volume":"16","author":"Y Xiao","year":"2026","unstructured":"Xiao Y, Zhu D, Zhou X. Advances in cytokines and inflammatory mechanisms in the pathogenesis of interstitial cystitis\/bladder pain syndrome. Biomolecules. 2026;16:138.","journal-title":"Biomolecules"},{"key":"6793_CR18","doi-asserted-by":"publisher","first-page":"E136","DOI":"10.1111\/j.1464-410X.2010.09911.x","volume":"108","author":"JH Shie","year":"2011","unstructured":"Shie JH, Kuo HC. Higher levels of cell apoptosis and abnormal E-cadherin expression in the urothelium are associated with inflammation in patients with interstitial cystitis\/painful bladder syndrome. BJU Int. 2011;108:E136\u201341.","journal-title":"BJU Int"},{"key":"6793_CR19","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.eururo.2003.11.021","volume":"45","author":"J Nordling","year":"2004","unstructured":"Nordling J, Anjum FH, Bade JJ, Bouchelouche K, Bouchelouche P, Cervigni M, et al. Primary evaluation of patients suspected of having interstitial cystitis (IC). Eur Urol. 2004;45:662\u20139.","journal-title":"Eur Urol"},{"key":"6793_CR20","first-page":"624","volume":"4","author":"G Ens","year":"2015","unstructured":"Ens G, Garrido GL. Role of cystoscopy and hydrodistention in the diagnosis of interstitial cystitis\/bladder pain syndrome. Transl Androl Urol. 2015;4:624\u20138.","journal-title":"Transl Androl Urol"},{"key":"6793_CR21","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4103\/tcmj.tcmj_172_23","volume":"36","author":"WR Yu","year":"2023","unstructured":"Yu WR, Jiang YH, Jhang JF, Kuo HC. Cystoscopic characteristic findings of interstitial cystitis and clinical implications. Tzu Chi Med J. 2023;36:30\u20137.","journal-title":"Tzu Chi Med J"},{"key":"6793_CR22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/S0090-4295(99)80333-1","volume":"49","author":"MP O'Leary","year":"1997","unstructured":"O\u2019Leary MP, Sant GR, Fowler FJ Jr, Whitmore KE, Spolarich-Kroll J. The interstitial cystitis symptom index and problem index. Urology. 1997;49:58\u201363.","journal-title":"Urology"},{"key":"6793_CR23","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.urology.2014.04.011","volume":"84","author":"PC Bosch","year":"2014","unstructured":"Bosch PC. Examination of the significant placebo effect in the treatment of interstitial cystitis\/bladder pain syndrome. Urology. 2014;84:321\u20136.","journal-title":"Urology"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-026-06793-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-026-06793-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-026-06793-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T12:30:32Z","timestamp":1783513832000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-026-06793-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":23,"alternative-id":["6793"],"URL":"https:\/\/doi.org\/10.1007\/s00192-026-06793-3","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"24 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol received Taipei Medical University Institutional Review Board approval (Approval no.: N201510065) and was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}